). Most ECG measures were stronger markers of risk for cardiovascular death than for all-cause mortality or noncardiovascular death. Adding these intervals to a comprehensive model of cardiorenal risk factors increased the C-statistic for cardiovascular death from 0.77 to 0.81 (P,0.001). Furthermore, adding ECG metrics to the model adjusted for standard risk factors resulted in a net reclassification of 12.1% (95% confidence interval 8.1%-16.0%). These data suggest common ECG metrics are independent risk factors for cardiovascular death and enhance the ability to predict death events in a population with CKD.
The use of a resting 12-lead electrocardiogram (ECG) as a screening test in intermediate risk populations such as those with CKD remains controversial. Although the US Preventive Services Task Force does not recommend routine ECG screening for the purposes of cardiovascular risk stratification in asymptomatic adults at low risk for coronary heart disease events, 1,2 inadequate data exist on utilizing ECGs in intermediate risk populations. CKD comprises greater than 10% of the world's population 3 and is a known risk factor for cardiovascular events and death. 4 ECGs are not routinely obtained in most general internal medicine or nephrology practices where most CKD patients are being managed in the United States.
The ECG, which provides a comprehensive overview of cardiac rhythms and conduction, is obtained routinely in nearly all inpatients and in the preoperative setting. Most ECGs obtained in clinical practice are produced from digital signaling. In addition, ECG interpretation software is built into many modern ECG systems and contains algorithms to assess reliably the cardiac rhythm and measure the heart rate and PR, QRS, and QT intervals. 5 These metrics provide important insight into autonomic function, atrioventricular conduction, ventricular depolarization, and repolarization. In communitybased elderly participants with early CKD, ECG measures were independently associated with all-cause mortality. 6, 7 The mean age in these studies was 75 years, the mean eGFR was 50-60 ml/min per 1.73m 2 and greater than 80% of the study population was white thus limiting the generalizability of these findings to a larger CKD population, especially those with moderate to advanced CKD. In contrast, among participants with end stage renal disease on hemodialysis from the German Diabetes and Dialysis (4D) Study, common ECG measures including the QRS duration, QT interval and heart rate were not independently associated with clinical events. 8 Given its ubiquitous availability and the potential for further risk stratifying kidney disease patients, a more detailed understanding of the utility of ECG testing in a diverse CKD population is necessary. Further, limited studies have assessed rigorously the utility of ECG metrics in improving risk stratification of individuals with CKD above and beyond the assessment of cardiorenal risk factors. To address this knowledge gap, we evaluated a panel of five commonly available ECG parameters including measures of standard intervals and left ventricular hypertrophy (LVH). We assessed each as a potential independent risk factor for and predictor of all-cause mortality, cardiovascular death, noncardiovascular death, and incident cardiovascular disease in a diverse cohort of individuals with CKD.
RESULTS
Among 3587 participants included in this analysis, the mean (SD) age was 58 (611) years, 45% were women, and 41% were black. Approximately one-third of participants had a baseline history of cardiovascular disease. In addition, the prevalence of abnormal ECG metrics in the The Chronic Renal Insufficiency Cohort (CRIC) study included the following: 542 (15%) had a PR$200 ms, 1065 (30%) had a QRS$100 ms, 295 (8%) participants had a QT c $450 ms in men or 460 ms in women, and 315 (9%) had LVH (Table 1, Supplemental  Table 1 ). In addition, the distribution of heart rates included 1196 (33%) individuals with a rate ,60 beats per minute (bpm), 2285 (64%) with a rate between 60 and 90 bpm, and 105 (3%) with a rate $90 bpm. In general, participants with longer PR, QRS, and QT c intervals were more likely than those with shorter intervals to be older, have more prevalent cardiovascular disease, diabetes, hypertension, and a lower eGFR at entry. Participants with higher heart rates were younger, had more diabetes, a lower eGFR, and more proteinuria than those with lower heart rates, but there were no significant differences in the prevalence of cardiovascular disease and hypertension. Finally, we noted that higher left ventricular mass index and lower left ventricular ejection fraction were associated with longer PR, QRS, and QT c intervals. Abnormalities in these echocardiographic measures were also associated with the presence of ECG-based LVH. Higher heart rate was associated with lower left ventricular ejection fraction, but not with left ventricular mass index.
During a median follow-up of 7.5 (interquartile range, 6.2-8.6) years, there were 750 deaths in this cohort with an annual mortality rate of 3.0% per year. We adjudicated the initial 497 deaths and identified 256 cardiovascular (1.1% per year) and 241 noncardiovascular deaths (1.0% per year). Finally, in the subgroup of 2492 CRIC participants without any baseline history of heart failure, coronary heart disease, or stroke, we identified 242 cases of incident heart failure (incident rate 1.5% per year) and 136 cases of incident myocardial infarction (MI) (incident rate 0.8% per year).
An abnormality in any of the five ECG metrics was associated with either death or cardiovascular death in unadjusted analysis ( Figure 1A and B). Only QT c and heart rate were associated with noncardiovascular death in the unadjusted models ( Figure 1C ). After multivariable adjustment, the PR interval was an independent risk marker for cardiovascular death in both the categorical and linear analyses ( Table 2 ). In addition, both the QRS and QT c intervals were associated with death and cardiovascular death after multivariable adjustment. Abnormalities in QRS and QT c appeared to be stronger risk factors for cardiovascular death than all-cause mortality. In particular, compared with participants with a normal QRS (,100 ms) or QT c (,450 ms men or ,460 ms women) interval, those with a wide QRS interval or prolonged QT c had an adjusted 65-80% higher incidence of cardiovascular death. An increase in heart rate was independently associated with all three mortality outcomes. It was also the only ECG measure that was an independent marker for noncardiovascular death. Electrocardiographic-based LVH and the associated Cornell voltage (reflecting the severity of LVH) were not associated with any of these outcomes.
Among the subgroup of 2492 CRIC participants without any baseline history of heart failure, coronary heart disease, or stroke, we detected modest associations between the ECG intervals and incident heart failure and MI (Table 3) . Compared with participants with a QRS duration ,100 ms, individuals with a QRS, 100-119 ms had an approximate 60% increase in both incident heart failure and MI after multivariable analysis. The risk was 116% higher among those with a QRS$120 ms. A long QTc was associated with incident heart failure only. The PR interval, heart rate, and ECG-LVH were not associated with any of the incident cardiovascular disease outcomes. Additional evaluation of the corrected QT interval and left ventricular voltage in the subgroup of participants with a QRS,120 ms yielded similar findings to the primary analysis. An increased QT c was associated with higher risk for all three mortality outcomes after adjustment for age, sex, race, clinical site, history of cardiovascular disease, systolic and diastolic blood pressure, total cholesterol, HDL, body mass index (BMI), smoking, diabetes, eGFR, proteinuria, serum calcium, serum phosphate, serum potassium, and medication use (per 10 ms increase in the QT c , hazard ratio [HR], 1.09; 95% confidence interval [95% CI], 1.05-1.13 for all-cause mortality; HR, 1.14; 95% CI, 1.07-1.22 for cardiovascular death; HR, 1.08; 95% CI, 1.01-1.16 for noncardiovascular death). An increase in left ventricular voltage was now an independent risk factor for mortality (per 1 mm increase in voltage, HR, 1.02; 95% CI, 1.00-1.03 for all-cause mortality; HR, 1.03; 95% CI, 1.00-1.05 for cardiovascular death; HR, 1.01; 95% CI, 0.99-1.04 for noncardiovascular death).
Subgroup Analyses and Interaction Testing for Cardiovascular Death
In the additional analyses that included echocardiographic measures of left ventricular mass index and left ventricular ejection fraction, we noted that PR, QRS, and heart rate remained significant risk markers for cardiovascular death (Supplemental Table 2 ). In addition, the corrected QT interval was no longer associated with cardiovascular death after the addition of these two echocardiographic measures.
After assessing potential effect modification between each ECG interval and either sex or race, we detected significant interactions between the RR interval and sex (RR per 50 ms☓sex, P interaction =0.01; RR categorical☓sex, P interaction =0.02). A higher heart rate appeared to be a stronger risk factor for cardiovascular death among women compared with men. For each 50 ms decrease in the RR interval, women had a 14% higher incidence of cardiovascular death after multivariable analysis (HR, 1.14; 95% CI, 1.05-1.24). No significant association was observed in men (HR, 1.00; 95% CI, 0.94-1.06). Similar findings were observed in the categorical analysis. Compared with women with a heart rate ,60 bpm, those with higher heart rates had significant risks for cardiovascular death (heart rate 60-90 bpm, HR, 2.27; 95% CI, 1.28-4.02; heart rate $90 bpm, HR, 3.60; 95% CI, 0.96-13.50). Similar to the linear analysis, no significant associations were observed between these categorical cut points and cardiovascular death among men. In addition, there were no other significant interactions between PR, QRS, QTc, and Cornell voltage and sex. Further, no significant interactions were observed between any of the five ECG metrics and race (P interaction .0.01).
ECG Metrics and the Prediction of Cardiovascular Death
Over a 5-year period, the inclusion of the five ECG metrics enhanced the prediction of cardiovascular death. In this population of individuals with CKD, the prediction of cardiovascular death using a set of standard risk factors including age, sex, race, history of cardiovascular disease, blood pressure, total cholesterol, HDL, BMI, diabetes, smoking, eGFR, and proteinuria yielded a C-statistic of 0.77; 95% CI, 0.75-0.80 ( Figure 2) . After adding the five ECG metrics to this comprehensive risk factor model, the C-statistic increased to 0.81; 95% CI, 0.78-0.83. A similar improvement was observed in the different CKD subgroups including blacks, whites, men, and women. The integrated discrimination improvement was 2.7%; 95% CI, 0.8%-4.6%, P=0.001. The addition of ECG metrics to the model that adjusted for a comprehensive panel of kidney disease and cardiovascular risk factors resulted in a net reclassification of 12.1%; 95% CI, 8.1%-16.0% of the overall sample (Table 4 ). The upward reclassification of participants that eventually died of cardiovascular causes was greater than the downward reclassification of individuals who survived.
DISCUSSION
In this multicenter cohort of 3587 CKD participants, we demonstrated that the PR interval, QRS duration, and corrected QT interval were independent risk markers for cardiovascular death. These measures had stronger associations with cardiovascular death than they did with either allcause mortality or noncardiovascular death. Higher heart rates were associated with a similar increase in risk across all three mortality outcomes. Only modest associations were observed between the QRS and QT intervals and incident cardiovascular disease. Our analyses included common electrocardiographic The adjusted analysis included the following covariates: age, sex, race, clinical site, history of cardiovascular disease (coronary artery disease, congestive heart failure, peripheral vascular disease, and stroke), systolic blood pressure, diastolic blood pressure, total cholesterol, HDL, body mass index, current smoking status, diabetes, eGFR, log (urine total protein excretion), serum calcium, serum phosphate, serum potassium, medication use (b-blockers, calcium channel blockers, and statins). In addition, with the exception of the assessed ECG parameter, the adjusted analysis included the other four metrics.
J Am Soc Nephrol 27: ccc-ccc, 2015 ECG Metrics and Mortality in CKD measurements that are reported automatically during ECG acquisition by most software programs and do not require additional interpretation by a physician reviewer. This combination of measures resulted in enhanced discrimination for cardiovascular mortality, with a significant increase in the C-statistic and improved reclassification that was driven by identifying higher risk participants. These findings along with the modest expense and widespread availability of electrocardiography suggest that broader use of ECGs among individuals with CKD may positively impact the care of the CKD population by permitting improved targeting of cardiovascular risk reduction strategies. Recent reports from the US Preventive Services Task Force have highlighted the importance of evaluating a series of ECG metrics simultaneously for the purposes of screening, especially intermediate risk populations. 1, 9 The 3587 CKD participants in our sample had a mortality rate of 3% per year, which is significantly higher than that observed in most populationbased cohorts. The addition of common ECG metrics resulted in significant improvement in the discrimination (C-statistic) for cardiovascular death. Further, ECG metrics appeared to enhance prediction for cardiovascular death to a greater degree in blacks compared with whites. Our analysis also identifies a significant risk reclassification that was driven primarily by identifying higher risk participants. The highest risk category in the reclassification table consisted of a .5% per year cardiovascular death rate and equals the corresponding death rate observed in patients with systolic heart failure. [10] [11] [12] These findings suggest that routine ECG evaluation in the CKD population is likely to be more helpful than screening low risk populations.
One of the important questions arising from these data remains how abnormalities in common ECG measures can be utilized to alter cardiovascular mortality risk in this population. ECG abnormalities reflect the electrophysiologic health of the myocardium and may reflect a combination of dysregulation in ionic currents, metabolic changes, alterations in serum electrolytes, and secondary effects of medications. Our analyses also demonstrate strong electromechanic correlations as abnormalities in all five ECG measures were associated with left ventricular dysfunction and increased left ventricular mass. These findings help to explain the stronger associations observed between ECG measures and cardiovascular death compared with noncardiovascular death. Further, the modest associations observed with heart failure and MI suggest that alternative cardiac diseases and pathways contribute to the higher mortality risk. Individuals with CKD are known to be at higher risk for fatal arrhythmias and sudden cardiac death. 13, 14 Future clinical trials should evaluate whether the additional information from an ECG can identify a subgroup that may benefit from additional cardiac work-up such as stress testing, echocardiography, or cardiac/coronary computed tomography scanning. A further understanding of the cardiac substrate through additional diagnostic tests may identify CKD patients that will benefit from aggressive cardioprotective therapies including b-blockers, mineralocorticoid receptor blockers, revascularization, and even implantable cardioverter defibrillator placement.
Our sample of 3587 CKD participants is the largest population of kidney disease individuals to undergo systematic assessment of the significance of abnormalities of common ECG measures across various subgroups. ECG measures had a similar association with cardiovascular death in the various subgroups including blacks and whites, and men and women. We were able to assess the independent effects of ECG metrics after adjusting for a series of potential confounders including a cystatin C and creatinine-based eGFR equation, 24-hour proteinuria, and serum concentrations of calcium, phosphorus, and potassium. Our study findings, especially pertaining to the enhanced prediction of cardiovascular mortality, will need to be validated in other populations of individuals with CKD. Also, this study was composed of research volunteers. As such, the results may The adjusted analysis included the following covariates: age, sex, race, clinical site, systolic blood pressure, diastolic blood pressure, total cholesterol, HDL, body mass index, current smoking status, diabetes, eGFR, log (urine total protein excretion), serum calcium, serum phosphate, serum potassium, medication use (b-blockers, calcium channel blockers, and statins). In addition, with the exception of the assessed ECG parameter, the adjusted analysis included the other four metrics.
not be generalizable to all individuals with CKD of similar severity. In summary, several common ECG metrics appear to have stronger independent associations with cardiovascular death compared with noncardiovascular death among individuals with CKD. These measures also improve the prediction of cardiovascular death in the setting of CKD above and beyond standard clinical risk factors. Future research is needed to evaluate the clinical effectiveness of ECG-based screening strategies linked to targeted interventions.
CONCISE METHODS

Study Population
The CRIC study is a large, multicenter, multiracial cohort study established to understand the progression of cardiovascular and renal disease among individuals with CKD. The study enrolled participants between June 2003 and September 2008. Individuals who were between 21 and 74 years and had an eGFR between 20 and 70 ml/min per 1.73 m 2 were eligible for the study.
The age and eGFR criteria were specifically designed to facilitate evaluation of the progression and implications of CKD across a wide spectrum of mild to moderate kidney dysfunction and age. Details on recruitment and design have been published previously. 15 The study protocol complies with the Declaration of Helsinki, and the institutional review boards at the seven participating centers approved the study protocol. All study participants provided written informed consent.
In brief, CRIC recruited 3939 men and women aged 21-74 years. The participants underwent clinical evaluations at baseline and annual visits with interim telephone interviews at 6-month intervals. Among the 3939 participants enrolled at baseline, we excluded 269 participants who were missing at least one of the five ECG metrics assessed in this study. From the remaining 3670 participants, we excluded those with a baseline ECG demonstrating either atrial fibrillation, atrial flutter, or atrial tachycardia (n=51). Atrial fibrillation and atrial flutter result in variations of heart rate and the QT interval and thus do not provide a reliable measure of these parameters. We also excluded participants with a nonphysiologic PR interval defined as one that is less than 100 ms, suggestive of accessory pathway conduction (n=42). In total, 83 participants had either atrial fibrillation/ atrial tachycardia or a PR interval ,100 ms on the baseline ECG resulting in a final analytical sample of 3587 study participants. Information on baseline confounders was obtained during the initial visit and included sociodemographics, lifestyle risk factors, medical history, and medication use. Blood pressure, 16 anthropometrics, 17 and other clinical variables such as smoking status and diabetes were collected using standard protocols. Prevalent cardiovascular disease included any history of coronary heart disease, heart failure, peripheral arterial disease, and stroke. Blood was obtained from participants in the fasting state and assayed for serum creatinine, cystatin C, calcium, sodium, potassium, phosphorus, total cholesterol, HDL, LDL, triglycerides, albumin, and hemoglobin. Hemoglobin was measured locally at a laboratory associated with each clinical center. All other measurements were performed at a central laboratory at the University of Pennsylvania. Estimated GFR was calculated from serum creatinine and cystatin C using the CRIC-based equation. 18 Twenty-four hour urine samples were obtained and measured for albumin.
Cardiac Measurements
Twelve-lead electrocardiograms were recorded in all participants using standardized procedures 19 and identical electrocardiographic equipment (MAC 1200; GE Medical Systems Information Technologies, Milwaukee, WI). Digitally recorded ECGs were transmitted for analysis to the CRIC ECG reading center located at Wake Forest University, Winston Salem, NC. After being visually checked for quality, the study ECGs were automatically processed using the 2001 version of the GE Marquette 12-SL program (GE Medical Systems Information Technologies). The PR and QT intervals were calculated as single global measures from the earliest onset to the latest off-set of the relevant waveforms. Heart rate was calculated from the RR interval (heart rate [in bpm]=60/RR [in ms]*1000). The PR, QRS, QT, and heart rate (RR) durations were evaluated automatically in normal sinus rhythm using these recordings. Additional details on how each ECG metric was assessed are provided: the PR interval was assessed both as a linear variable (per 10 ms) and a dichotomous one ($200 ms) based on clinical criteria that define PR prolongation or first degree atrioventricular block. The QRS interval was evaluated as a linear variable (per 10 ms) and categorized into three groups (,100 ms, 100-119 ms, and $120 ms). A QRS interval between 100 and 119 ms reflects intraventricular conduction delay and is suggestive of fibrosis and conduction system disease. 20 In addition, a QRS interval $120 ms is defined as bundle branch block. The QT c interval was calculated using Bazett's formula 21 and was assessed both as a linear variable (per 10 ms) and dichotomous one. QT c prolongation was defined according to national guidelines, which recommend cut points of 460 ms or longer in women and 450 ms or longer in men. 21 Since the QT interval, which includes the QRS duration, will automatically prolong in any ventricular conduction defect, special considerations and adjustments for the QRS duration were necessary. [22] [23] [24] As a result, we also evaluated the significance of the QT c interval among the subgroup of participants who were not considered to have significant delays in ventricular conduction (i.e., QRS duration ,120 ms). Heart rate was assessed as both a linear variable (per 50 ms) and categorized into three groups (in units of bpm): less than 60, 60-90, and greater than 90. Electrocardiographic LVH was assessed utilizing the Cornell voltage criteria based on the sum of the S-wave in V3 and R-wave in aVL. 25, 26 LVH was evaluated both as a linear variable (per 100 microvolts) and dichotomized by the presence or absence of LVH, which is defined as a Cornell voltage greater than 28,000 microvolts in men and greater than 20,000 microvolts in women. 25, 26 Both LVH and intraventricular conduction delay alter QRS patterns, and a prolonged QRS duration may impact the accuracy of the ECG criteria for LVH. Multiple studies have also suggested that the diagnosis of LVH should not be attempted in the setting of bundle branch block. 27 As a result, in addition to evaluating LVH in all CRIC participants, we also evaluated its significance in the subgroup with a QRS duration ,120 ms.
Echocardiography was performed approximately one year after enrollment into the CRIC study. Studies were performed at the individual sites according to the American Society of Echocardiography guidelines and assessed cardiac structure and function. 28 All data were sent to the core echocardiography laboratory (University of Pennsylvania) for measurement and analysis. Left ventricular mass was calculated using the area-length method and indexed to height 2.7 . 28 In addition, left ventricular systolic function was assessed.
Left ventricular end-diastolic and end-systolic volumes were calculated using the modified biplane method, and ejection fraction was calculated as [(end-diastolic volume minus end-systolic volume)/ (end-diastolic volume)].
Outcome Variables
We assessed all-cause mortality, cardiovascular death, and noncardiovascular death. In addition, incident heart failure and MI were evaluated. Deaths were ascertained from next of kin, retrieval of death certificates or obituaries, review of hospital records, and linkage with the social security death master file. All deaths to March 31, 2013, were included in these analyses. We also adjudicated cardiovascular death and noncardiovascular death events. For inpatient deaths, two physicians reviewed medical records, death certificates, and autopsy reports when available. Based on this review, the physician reviewers adjudicated the death as one being due to MI, coronary heart disease, congestive heart failure, or another cardiovascular cause. The etiology for other deaths especially those that occurred among outpatients were adjudicated by a nurse research coordinator using death certificate data. As part of their evaluation, a mortality event was attributable to a cardiovascular cause when the primary diagnosis on the death certificate included MI, coronary heart disease, cardiorespiratory arrest, or congestive heart failure. Individuals who had a diagnosis of a severe, noncardiovascular illness such as cancer, sepsis, systemic inflammatory response syndrome, dementia, gastrointestinal bleeding, or severe hemorrhage were labeled as having a noncardiovascular death.
Incident heart failure and MI were also assessed in the subgroup of 2492 CRIC participants without a baseline history of heart failure, coronary heart disease, or stroke. These outcomes were adjudicated using well defined criteria that have been described previously. 15, 29 
Statistical Analysis
The baseline characteristics of CRIC participants are described across the a priori specified ECG categories. Separate Cox proportional hazards models were fitted to assess the association between each ECG measure and outcome. Each ECG parameter was modeled both as a linear and categorical variable, with quadratic splines used to explore a potential non-linear relationship between each ECG measure and outcome. 30 For the evaluation of the three mortality outcomes, multivariable analysis adjusted for potential confounders of the association between each ECG metric and death. Adjusted models included the following covariates: demographic characteristics (age, sex, and race/ethnicity), clinical center, cardiovascular disease at baseline, cardiovascular risk factors including current smoking and diabetes, systolic blood pressure, diastolic blood pressure, BMI, total cholesterol, HDL, eGFR, 24-hour proteinuria (log of urinary protein excretion), serum calcium, serum phosphorus, serum potassium, and baseline medications (b-blocker, calcium channel blocker, and statin). In addition, multivariable models included all five ECG variables that were assessed. For incident heart failure and MI, the multivariable modeling included the same covariates except prevalent heart failure, coronary heart disease or stroke. Additional analyses were performed to evaluate the QT c interval and LVH as potential risk factors in the subgroup with a QRS,120 ms. There was no evidence of violation of the proportional hazards assumption based on cumulative Martingale residuals. 31 We also performed additional evaluation for cardiovascular death and adjusted for echocardiographic-based measures of left ventricular mass index and ejection fraction. Based on a priori hypotheses, we tested for interactions between each of the five ECG metrics and sex and race for the outcome of cardiovascular death.
We evaluated the ability of ECG metrics to improve cardiovascular mortality prediction within 5 years of follow-up in this CKD cohort. We first calculated the c-statistic, a measure of discrimination, 32 for the base model for cardiovascular mortality, which included a standard set of predictors including age, sex, race, history of cardiovascular disease, smoking, diabetes, systolic and diastolic blood pressure, BMI, total cholesterol, HDL, eGFR, and proteinuria (24 hour collection). We then evaluated the C-statistic after adding the five ECG metrics to the model. We calculated the net reclassification improvement (NRI) 33 to assess how well the addition of ECG metrics reclassified cases into higher risk strata and non-cases into lower risk categories. The NRI is estimated according to the method by Pencina 33 and is defined as {([number of events reclassified higher -number of events reclassified lower]/number of events)+([number of non-events reclassified lowernumber of non-events reclassified higher]/number of non-events)}. Since the mortality rate in the CRIC study is 3% per year, we used annualized cut points of 1% and 5% to define the low, medium, and high risk groups. In particular, we assessed reclassification over a 5-year period and defined the low risk group as having an annualized rate of death ,1% (corresponds to less than 5% over 5 years). The intermediate risk group was composed of participants who had an annual death rate between 1% and 5% (corresponds to 5-25% over 5 years). We defined the high risk group as having a death rate $5% per year. Finally, we estimated the integrated discrimination improvement, 33 defined as the average increase in predicted risk among cases, plus the analogous average decrease among non-cases, afforded by information of ECG metrics. In contrast to the three-category NRI measures, the integrated discrimination improvement is calculated using predicted risks and is not affected by choice of cutoff values. Analyses were performed using SAS 9.3 (SAS Institute Inc., Cary, NC). All statistical tests were two-sided, and P values ,0.05 were considered significant.
